About Index Trending news
Analyze
Top 50 Pricing
Bristol-Myers Squibb

Bristol-Myers Squibb

Work at Bristol-Myers Squibb? Add yourself to this profile

Bristol-Myers Squibb

Global Specialty Care BioPharma

Elsewhere

Alexa global traffic share

Twitter followers

Employees

Team size

10000+
Locations
HQ
Headquarters
Xconomy , New York Times Bits

Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer

Health Earnings
Xconomy

Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal

The Motley Fool

3 Top Big Pharma Stocks to Buy Now

The Motley Fool

3 Stocks Any Investor Can Buy

Earnings Stock markets
The Motley Fool

5 Stocks to Supplement Your Social Security Benefits

The Motley Fool

3 Reasons Investors Can Buy Bristol-Myers Squibb

The Motley Fool

Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb

The Motley Fool

Bristol-Myers Squibb Co Stock in 4 Charts

Stock markets Health
The Motley Fool

3 Reasons Bristol-Myers Squibb Co Stock Could Rise

Health Stock markets
The Motley Fool

Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth --

Health Stock markets
The Motley Fool

Balance Sheet Brawl: Pfizer Vs. Bristol-Myers Squibb --

Stock markets Health
The Motley Fool

Bristol-Myers Squibb Finally Hits a Roadblock --

The Motley Fool

Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller? --

The Motley Fool

Bristol-Myers Squibb's Opdivo May Change How We Treat Pancreatic Cancer --

The Motley Fool

Did the Immuno-Oncology Gap Between Bristol-Myers Squibb and Merck & Co. Just Grow? --

Health Earnings Stock markets
GeekWire

Bristol-Myers Squibb relocating 40 Seattle scientists to San Francisco five years after acquiring ZymoGenetics